Aspirin reduce bowel cancer

Aspirin reduce bowel cancer story

The study was conducted by researchers at the School of Public Health and Harvard Medical School, Boston; Brigham and Women's Hospital; and Massachusetts General Hospital. The study was published in the medical journal JAMA reviewed by Oncology and was funded by the National Institutes of Health.

You can read the study online for free.
The study was generally well covered by the media in the UK, from aspirin as a cheap drug that will reduce the risk of cancer. Most of the stories reflected the researchers caution that people should be informed about the possible side effects of regular aspirin treatment. They also warned that the use of aspirin should not be seen as a substitute for the detection of colon cancer.

 Aspirin reduce bowel cancer of research 

This was a study of two cohorts of US aimed to examine the effects of aspirin on cancer risk - both in general and for specific type of cancer.
Aspirin is a well established for the treatment and prevention of cardiovascular disease drug. Many large trials of people taking aspirin regularly for cardiovascular disease have also suggested that it can reduce the overall risk of cancer as well.
There were limited data to provide reliable risk information by type of cancer, with the exception of a link to cancer (colon) Colorectal. As such, the Working Group Preventive Services United States recently recommended the use of aspirin to prevent colon cancer and cardiovascular disease for many adults in the United States. However, questions remain about the dose and duration of optimal use, and if there may be effects on other cancers. This study aimed to examine this.
The main limitations of observational cohort studies are the possibility that other features of health and lifestyle of individuals may be involved in these links.

Posted in: Health&Beauty